64 related articles for article (PubMed ID: 3329168)
1. Prolonged remission of Cushing's disease following bromocriptine therapy.
McKenna MJ; Linares M; Mellinger RC
Henry Ford Hosp Med J; 1987; 35(4):188-91. PubMed ID: 3329168
[No Abstract] [Full Text] [Related]
2. [Clinical remission in Cushing's disease through treatment with sodium valproate and bromocriptine].
García Rojas JF; Mangas Rojas A; Barba Chacón A; García Osle M; Zamora Madaria E
Rev Clin Esp; 1991 Jan; 188(1):37-40. PubMed ID: 2063025
[TBL] [Abstract][Full Text] [Related]
3. [Unique type of Cushing's disease in clinical profile: cyclic Cushing's syndrome and Cushing's disease with favorable outcome to a high daily dose of bromocriptine].
Yasuda K; Miura K
Nihon Naibunpi Gakkai Zasshi; 1994 Jan; 70(1):11-6. PubMed ID: 7958078
[TBL] [Abstract][Full Text] [Related]
4. Six year remission of ACTH-dependent Cushing's syndrome using bromocriptine.
Atkinson AB; Kennedy AL; Sheridan B
Postgrad Med J; 1985 Mar; 61(713):239-42. PubMed ID: 2984649
[TBL] [Abstract][Full Text] [Related]
5. [2 cases of Cushing's syndrome successfully treated with bromocriptine].
Medraś M; Plamieniak Z; Bidzińska B
Pol Tyg Lek; 1988 Sep; 43(39):1263-5. PubMed ID: 2854251
[No Abstract] [Full Text] [Related]
6. Long term bromocriptine therapy in Cushing's disease.
Kapcala LP; Jackson IM
J Endocrinol Invest; 1982; 5(2):117-20. PubMed ID: 6284830
[TBL] [Abstract][Full Text] [Related]
7. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and biochemical remission of Itsenko-Cushing disease during parlodel treatment].
Marova EI; Butrova SA; Pronin VS
Sov Med; 1978 Jun; (6):91-4. PubMed ID: 354026
[No Abstract] [Full Text] [Related]
9. Spontaneous remission in Cushing's disease.
Ishibashi M; Shimada K; Abe K; Furue H; Yamaji T
Arch Intern Med; 1993 Jan; 153(2):251-5. PubMed ID: 8422213
[TBL] [Abstract][Full Text] [Related]
10. Cushing's disease. A review.
Burch WM
Arch Intern Med; 1985 Jun; 145(6):1106-11. PubMed ID: 3923962
[TBL] [Abstract][Full Text] [Related]
11. Cushing's disease in a patient with a 'nonfunctioning' pituitary tumor. Spontaneous development and remission.
Gogel EL; Salber PR; Tyrrell JB; Rosenblum ML; Findling JW
Arch Intern Med; 1983 May; 143(5):1040-2. PubMed ID: 6089681
[TBL] [Abstract][Full Text] [Related]
12. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
13. [Cushing's syndrome].
Ojima M
Nihon Rinsho; 1993 Jan; 51 Suppl():112-9. PubMed ID: 8459538
[No Abstract] [Full Text] [Related]
14. Pregnancy after cyproheptadine treatment for Cushing's disease.
Griffith DN; Rose EJ
N Engl J Med; 1981 Oct; 305(15):893-4. PubMed ID: 7278892
[No Abstract] [Full Text] [Related]
15. [Non-invasive therapy of Cushing's syndrome].
Miura K
Nihon Naika Gakkai Zasshi; 1994 Sep; 83(9):1627-32. PubMed ID: 7798761
[No Abstract] [Full Text] [Related]
16. Bromocriptine for Cushing's disease.
Kennedy AL; Montgomery DA
Br Med J; 1977 Apr; 1(6068):1083-4. PubMed ID: 192411
[No Abstract] [Full Text] [Related]
17. Dynamic pituitary MRI has high sensitivity and specificity for the diagnosis of mild Cushing's syndrome and should be part of the initial workup.
Friedman TC; Zuckerbraun E; Lee ML; Kabil MS; Shahinian H
Horm Metab Res; 2007 Jun; 39(6):451-6. PubMed ID: 17578763
[TBL] [Abstract][Full Text] [Related]
18. Evaluation and treatment of Cushing's syndrome.
Nieman LK; Ilias I
Am J Med; 2005 Dec; 118(12):1340-6. PubMed ID: 16378774
[TBL] [Abstract][Full Text] [Related]
19. [Bromocryptin in the treatment of Itsenko-Cushing's disease].
Vasiukova EA; Zefirova GS; Ibragimova GV; Mkrtumian AM; Khaĭkina MB
Sov Med; 1979 Jun; (6):65-9. PubMed ID: 224516
[No Abstract] [Full Text] [Related]
20. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
